Skip to main content
skinEvidence: Grade B

Using Your MitoRed MitoPRO 300 for Psoriasis Treatment

Published: Last updated:

Device-specific protocol for Psoriasis using the MitoRed MitoRed MitoPRO 300 (630/660/830/850nm, 168 mW/cm²)

Your MitoRed MitoPRO 300 Protocol for Psoriasis

Wavelengths

630nm, 660nm, 830nm, 850nm

Session Time

1 min

Target Dose

9.5 J/cm²

Distance

6 inches

Frequency

3-5x/week

Timeline

4-12 weeks

Why MitoRed MitoPRO 300 for Psoriasis?

The MitoRed MitoRed MitoPRO 300 emits at 630nm and 660nm and 830nm and 850nm, which provides a excellent match for Psoriasis treatment. Research for this condition recommends 633nm, 660nm, 830nm.

At 168 mW/cm² irradiance (at the recommended distance of 6 inches), you'll need approximately 1 minutes per session to reach the target dose of 9.5 J/cm². This falls within the recommended range of 4-15 J/cm² for Psoriasis.

The MitoRed MitoPRO 300 is a panel device with targeted coverage. For Psoriasis, you may need to treat each area separately if the affected zone is larger than the device's coverage.

MitoRed MitoPRO 300 Quick Specs

Price

$399

LEDs

60

Power

120W

FDA

Not registered

Evidence for Psoriasis

Red light therapy at 633-660nm may reduce psoriatic plaque severity by modulating T-cell inflammation and keratinocyte proliferation. Dose: 4-15 J/cm², 10-20 minutes, 3-5x/week for 4-12 weeks. Not the same as UV phototherapy (311nm). Evidence grade: B (moderate — limited but positive clinical data).

Same Condition, Different Devices

Research Basis

This content is informed by 47+ published peer-reviewed studies on photobiomodulation.